Blueprint Medicines Corporation ( NASDAQ: BPMC) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET ...

Core operating profit was up ... step changes in treatment with Blenrep or novel ADC treatment for multiple myeloma and depemokimab, or new long-acting IL-5 medicine for the treatment of severe ...

Signs of mold toxicity mirror symptoms of common health nuisances...but a nationally recognized mold remediator says exposure can lead to much greater health issues.

BY PAUL ECCLES, ANDJELA MILIVOJEVIC AND RACHEL SCHRAER ADDITIONAL REPORTING BY SHAFA’ATU SULEIMAN AND LAURA MARGOTTINI He ...

Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter 2024 earnings call. Bob Bradway will lead the call and be followed by a ...

The issues, which began at around 1.30pm UK time, are slowing down the website and playing ... ChatGPT to become the top app on Apple’s charts. As more Western users have flocked to DeepSeek ...

The 54-year-old is best remembered for his 78 at the SCG against the West Indies in 1996, rescuing Australia from 38 for 6 to take them home with a four off the final ball to chase down 173 with a ...

Gaza City, in the north of the enclave, is a shell of the bustling, rough-edged urban center it was before the war, with swathes of buildings destroyed by Israeli bombardments and piles of rubble and ...

Patients with stable asthma are keen to ‘step down’ their medication when appropriate, say researchers who surveyed GP patients across England. It follows another recent study from the same team who ...

Based on an Apple study, researchers have developed a free asthma management tool, now available as an app, or on the web.

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.